Charles Schwab’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Charles Schwab’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,667	Closed	-$10.2K	–	3644
2023 Q2	$10.2K	Hold	2,667	–	–	﹤0.01%	3596
2023 Q1	$7.44K	Hold	2,667	–	–	﹤0.01%	3542
2022 Q4	$7.21K	Hold	2,667	–	–	﹤0.01%	3540
2022 Q3	$13K	Hold	2,667	–	–	﹤0.01%	3501
2022 Q2	$29K	Hold	2,667	–	–	﹤0.01%	3484
2022 Q1	$37K	Hold	2,667	–	–	﹤0.01%	3561
2021 Q4	$64K	Buy	+2,667	New	+$62.9K	﹤0.01%	3487

Other funds holding BTCY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Charles Schwab's BTCY Position: Q3 2023 in Review

Charles Schwab sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2023, closing a stake of 2,667 shares — an estimated $10.2K sold.

Charles Schwab first reported a position in BTCY in Q4 2021 and held it in 7 quarters. The position peaked at $64K in Q4 2021. 22 funds tracked by Wall St. Rank hold BTCY as of Q3 2023.

Charles Schwab reported no remaining Biotricity, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Charles Schwab sold 2,667 Biotricity, Inc. Common Stock shares in Q3 2023, an estimated $10.2K.
Charles Schwab first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Charles Schwab's Biotricity, Inc. Common Stock position peaked at $64K in Q4 2021.
22 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.